SCHEMBL765886

SCHEMBL765886

COC(=O)[C@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL295130 1.00
SCHEMBL86348 1.00
Hydrochloric Acid SCHEMBL722401 0.97
SCHEMBL7105090 0.80 SMN1; SMN2 (0.46)
SCHEMBL1557617 0.80 SMN1; SMN2 (0.46)
SCHEMBL24072865 0.80 SMN1; SMN2 (0.46)
SCHEMBL28353496 0.80 TSHR (0.37)
SCHEMBL12447225 0.79
SCHEMBL6744299 0.79
Methyl 2-Methylbutanoate SCHEMBL1195352 0.79 TDP1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115657360-A Multicolor liquid crystal writing device and preparation method 山东蓝贝思特教装集团股份有限公司 2023-01-31 CN claimed
CN-111423393-A Synthetic method of seventeen-membered large cyclic lipopeptide natural compound 北京大学深圳研究生院 2020-07-17 CN claimed
CN-110467530-A A kind of Robison ester ((R)-(-) -3- hydroxy-2-methyl methyl propionate) and its derivative and its synthetic method SHANGHAI MUSE HEALTH TECH CO LTD 2019-11-19 CN claimed
US-12624051-B2 Macrocyclic compounds, compositions, and methods of using thereof GENZYME CORPORATION (US) 2026-05-12 US disclosed
CN-122011012-A (S) -tert-butyl ((2-methyl-7- (trimethylsilyl) hept-6-alkyne-1-yl) oxy) diphenyl silane and synthesis method and application thereof 山东省农业科学院 2026-05-12 CN disclosed
US-12545684-B2 CDK2 inhibitors BLUEPRINT MEDICINES CORPORATION (US) 2026-02-10 US disclosed
US-20260008785-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SCHRODINGER, LLC 2026-01-08 US disclosed
US-20260008786-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SCHRODINGER, LLC 2026-01-08 US disclosed
EP-4656240-A1 NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER Novartis AG (CH) 2025-12-03 EP disclosed
EP-4646416-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2025-11-12 EP disclosed
EP-4646414-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2025-11-12 EP disclosed
US-5397775-A 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1995-03-14 US disclosed
EP-0331524-B1 SYNTHESIS OF TRICHOSTATINS Japan Tobacco Inc. (JP) 1993-08-18 EP disclosed
EP-0549318-A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1993-06-30 EP disclosed
EP-0520292-A1 Chiral azetidinone derivatives and their use as dopants in liquid crystalline mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1992-12-30 EP disclosed
EP-0251408-B1 NOVEL ANTI-INFLAMMATORY AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION THE PROCTER & GAMBLE COMPANY (US) 1991-04-17 EP disclosed
US-4946999-A Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A JAPAN TOBACCO INC. (JP) 1990-08-07 US disclosed
EP-0331524-A2 Synthesis of trichostatins Japan Tobacco Inc. (JP) 1989-09-06 EP disclosed
EP-0251408-A1 Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation THE PROCTER & GAMBLE COMPANY (US) 1988-01-07 EP disclosed
US-4708966-A SUBSTITUTED DI-TERT-BUTYL PHENOL DERIVATIVES THE PROCTER & GAMBLE COMPANY (US) 1987-11-24 US disclosed